Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Han-Ming Lai"'
Autor:
Jia-Feng Chen, Shan-Fu Yu, Wen-Chan Chiu, Chi-Hua Ko, Chung-Yuan Hsu, Han-Ming Lai, Ying-Chou Chen, Yu-Jih Su, Hong-Yo Kang, Tien-Tsai Cheng
Publikováno v:
Diagnostics, Vol 14, Iss 4, p 452 (2024)
Long-term Glucocorticoid (GC) use results in compromised bone strength and fractures, and several treatment recommendations have been developed to prevent fractures, but none have been validated in a real-world setting. This study aims to create a tr
Externí odkaz:
https://doaj.org/article/c7f0d7449fe74dee9ff3c388e3ccf7ae
Autor:
Shan-Fu Yu, Jia-Feng Chen, Ying-Chou Chen, Yu-Wei Wang, Chung-Yuan Hsu, Han-Ming Lai, Hsiao-Ru He, Chi-Hua Ko, Wen-Chan Chiu, Tien-Tsai Cheng
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectiveTo explore the impact of seropositivity on systemic bone loss in rheumatoid arthritis (RA).MethodsWe conducted an interim analysis of the RA registry. Patients were examined with dual-energy X-ray absorptiometry at baseline and again 3 years
Externí odkaz:
https://doaj.org/article/221ba5402df742f6b3efad83cec2cdcf
Autor:
Shan-Fu Yu, Ming-Han Chen, Jia-Feng Chen, Yu-Wei Wang, Ying-Chou Chen, Chung-Yuan Hsu, Han-Ming Lai, Wen-Chan Chiu, Chi-Hua Ko, Hsiao-Ru He, Tien-Tsai Cheng
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: To establish a FRAX®-based prediction model for rheumatoid arthritis (RA)-associated fragility fracture. Methods: This study is a longitudinal, real-world, registry cohort study. Patients with RA were registered to start in September 201
Externí odkaz:
https://doaj.org/article/aa07e4ac830043a4a35d051479ec020c
Autor:
Ming-Han Chen, Shan-Fu Yu, Jia-Feng Chen, Wei-Sheng Chen, The-Ling Liou, Chung-Tei Chou, Chung-Yuan Hsu, Han-Ming Lai, Ying-Chou Chen, Chang-Youh Tsai, Tien-Tsai Cheng
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveTo compare changes in bone mineral density (BMD) in rheumatoid arthritis (RA) patients receiving three-year conventional synthetic disease-modifying anti-rheumatic drugs (csDMARD), tumor necrosis factor-α inhibitors (TNFi), and abatacept.Me
Externí odkaz:
https://doaj.org/article/05f4e47d12124530b1c058e88adc0d68
Autor:
Shan-Fu Yu, Jur-Shan Cheng, Ying-Chou Chen, Jia-Feng Chen, Chung-Yuan Hsu, Han-Ming Lai, Chi-Hua Ko, Wen-Chan Chiu, Yu-Jih Su, Tien-Tsai Cheng
Publikováno v:
BMC Geriatrics, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background We investigated the association of anti-osteoporosis medication with mortality risk in older adults with hip fractures and evaluated the influence of medication adherence on mortality. Methods We conducted a population-based cohor
Externí odkaz:
https://doaj.org/article/6163bf7726ac4df88d735c6da16adc7f
Autor:
Po-Heng Lin, Shan-Fu Yu, Jia-Feng Chen, Ying-Chou Chen, Han-Ming Lai, Wen-Chan Chiu, Chung-Yuan Hsu, Yu-Wei Wang, Hsiao-Ru He, You-Yin Chen, Chu-Yin Cheng, Tien-Tsai Cheng
Publikováno v:
PLoS ONE, Vol 16, Iss 8 (2021)
Objectives To explore the risk factors for fragility fractures in rheumatoid arthritis (RA) patients using a 3-year longitudinal, observational cohort study. Methods This RA registry study included consecutive RA patients in the outpatient clinic of
Externí odkaz:
https://doaj.org/article/ad57c4411a6e444186f1d42164f20dd5
Autor:
Chung-Yuan Hsu, Jia-Feng Chen, Yu-Jih Su, Ying-Chou Chen, Han-Ming Lai, Shan-Fu Yu, Hsiao-Ru He, Tien-Tsai Cheng
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Background: Rheumatoid arthritis (RA) is associated with poor bone mineral density (BMD). We designed the current study owing to the lack of long-term prospective studies regarding whether a high disease activity leads to increased bone loss. Methods
Externí odkaz:
https://doaj.org/article/a740867562e24b47980faeae5b6f0633
Autor:
Tien-Tsai Cheng, Shan-Fu Yu, Fu-Mei Su, Yin-Chou Chen, Ben Yu-Jih Su, Wen-Chan Chiu, Chung-Yuan Hsu, Jia-Feng Chen, Chi-Hua Ko, Han-Ming Lai
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-10 (2018)
Abstract Background Positive anticyclic citrullinated peptide (anti-CCP+) is associated with bone loss in patients with rheumatoid arthritis (RA). However, whether overall positivity or specific levels of anti-CCP are associated with prevalent fractu
Externí odkaz:
https://doaj.org/article/a76734df32d6439485bf18df301db1dd
Autor:
Ying-Chou Chen, Wen-Chan Chiu, Tien-Tsai Cheng, Han-Ming Lai, Shan-Fu Yu, Ben Yu-Jih Su, Chung-Yuan Hsu, Chi-Hua Ko, Jia-Feng Chen
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-5 (2017)
Abstract Background This study evaluated the effect of early anti-tumor necrosis factor (TNF) therapy in patients with severe rheumatoid arthritis (RA) on the subsequent risk of total knee replacement (TKR) surgery. Methods This retrospective observa
Externí odkaz:
https://doaj.org/article/71a6bab3dc3a4d149fc96ccadbc33441
Autor:
Yen-Nung Liao, Ching-Shen Liu, Tong-Rong Tsai, Yu-Chiang Hung, Shun-Jen Chang, Hong-Long Lin, Ying-Chou Chen, Han-Ming Lai, Shan-Fu Yu, Chung-Jen Chen
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 27, Iss 7, Pp 251-257 (2011)
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease. Prolonged complete remission is rare. Most patients with SLE need long-term treatment with glucocorticoid and immunomodulators. However, side effects because of the above me
Externí odkaz:
https://doaj.org/article/e6c23c4db7d74d23b444923ce38015e2